EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts

Jung Kim iD, Jeremy Haley iD, Jessica N Hatton iD, Uyenlinh L Mirshahi iD, H Shanker Rao iD, Mark F Ramos iD, Diane Smelser iD, Gretchen Urban iD, Kris Ann P Schultz iD, David J Carey iD, Douglas R Stewart iD

Genetics in Medicine Open · 2024 · 2 · 101846

DOI: 10.1016/j.gimo.2024.101846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics in Medicine Open, 2024. Verfasst von Jung Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Population-scale, exome-sequenced cohorts with linked electronic health records (EHR) permit genome-first exploration of phenotype. Phenotype and cancer risk are well-characterized in children with a pathogenic DICER1 (HGNC ID:17098) variant. Here, the prevalence, penetrance and phenotype of pathogenic germline DICER1 variants in adults was investigated in two population-scale cohorts.

Methods

Variant pathogenicity was classified using published DICER1 ClinGen criteria in the UK Biobank (469,787 exomes; unrelated: 437,663) and Geisinger (170,503 exomes; unrelated: 109,789) cohorts. In the UK Biobank cohort, cancer diagnoses in the EHR, cancer and death registry were queried. For the Geisinger cohort, the Geisinger Cancer Registry and EHR were queried.

Results

In the UK Biobank, there were 46 unique pathogenic DICER1 variants in 57 individuals (1:8,242;95%CI:1:6,362-1:10,677). In Geisinger, there were 16 unique pathogenic DICER1 variants (including one microdeletion) in 21 individuals (1:8,119;95%CI:1:5,310-1:12,412). Cohorts were well-powered to find larger effect sizes for common cancers. Cancers were not significantly enriched in DICER1 heterozygotes; however, there was a ~4-fold increased risk for thyroid disease in both cohorts. There were multiple ICD10 codes enriched >2-fold in both cohorts.

Conclusion

Estimates of pathogenic germline DICER1 prevalence, thyroid disease penetrance and cancer phenotype from genomically ascertained adults are determined in two large cohorts.

Schlagwörter

Stichwörter der Autor:innen

DICER1DICER1 syndromehealthcare populationpenetranceprevalence

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
  • Department of Genomic Health, Weis Center for Research, Geisinger Medical Center, Danville, PA USA.
  • International Pleuropulmonary Blastoma (PPB)/DICER1 Registry, Children's Minnesota, Minneapolis, MN.
  • Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN.
  • International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN.

ORCID-Profile: Jung Kim, Jeremy Haley, Jessica N Hatton, Uyenlinh L Mirshahi, H Shanker Rao, Mark F Ramos, Diane Smelser, Gretchen Urban, Kris Ann P Schultz, David J Carey, Douglas R Stewart

Förderung

  • NCI NIH HHS
  • Intramural NIH HHS
  • National Cancer Institute
  • Division of Cancer Epidemiology and Genetics

Zitieren

APA

Kim, J., Haley, J., Hatton, J. N., Mirshahi, U. L., Rao, H. S., Ramos, M. F., Smelser, D., Urban, G., Schultz, K. A. P., Carey, D. J., & Stewart, D. R. (2024). A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts. Genetics in Medicine Open, 2, 101846. https://doi.org/10.1016/j.gimo.2024.101846

Vancouver

Kim J, Haley J, Hatton JN, Mirshahi UL, Rao HS, Ramos MF, et al. A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts. Genetics in Medicine Open. 2024;2:101846. doi:10.1016/j.gimo.2024.101846

BibTeX
@article{Kim2024,
  author = {Kim, Jung and Haley, Jeremy and Hatton, Jessica N and Mirshahi, Uyenlinh L and Rao, H Shanker and Ramos, Mark F and Smelser, Diane and Urban, Gretchen and Schultz, Kris Ann P and Carey, David J and Stewart, Douglas R},
  title = {A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts},
  journal = {Genetics in Medicine Open},
  year = {2024},
  volume = {2},
  pages = {101846},
  doi = {10.1016/j.gimo.2024.101846}
}
Kostenlos starten →